Fletcher B - Search Results

1

The promise of nanotechnology for solving clinical problems in breast cancer.

Grobmyer SR, Morse DL, Fletcher B, Gutwein LG, Sharma P, Krishna V, Frost SC, Moudgil BM, Brown SC. Grobmyer SR, et al. Among authors: fletcher b. J Surg Oncol. 2011 Mar 15;103(4):317-25. doi: 10.1002/jso.21698. J Surg Oncol. 2011. PMID: 21337565 Review.

2

Tumor endothelial marker 8 expression in triple-negative breast cancer.

Gutwein LG, Al-Quran SZ, Fernando S, Fletcher BS, Copeland EM, Grobmyer SR. Gutwein LG, et al. Anticancer Res. 2011 Oct;31(10):3417-22. Anticancer Res. 2011. PMID: 21965755

3

Glucose deprivation enhances targeting of GLUT1 to lipid rafts in 3T3-L1 adipocytes.

Kumar A, Xiao YP, Laipis PJ, Fletcher BS, Frost SC. Kumar A, et al. Am J Physiol Endocrinol Metab. 2004 Apr;286(4):E568-76. doi: 10.1152/ajpendo.00372.2003. Epub 2003 Dec 9. Am J Physiol Endocrinol Metab. 2004. PMID: 14665446 Free article.

4

Glycogen phosphorylase is activated in response to glucose deprivation but is not responsible for enhanced glucose transport activity in 3T3-L1 adipocytes.

McInerney M, Serrano Rodriguez G, Pawlina W, Hurt CB, Fletcher BS, Laipis PJ, Frost SC. McInerney M, et al. Among authors: fletcher bs. Biochim Biophys Acta. 2002 Feb 15;1570(1):53-62. doi: 10.1016/s0304-4165(02)00154-x. Biochim Biophys Acta. 2002. PMID: 11960689

5

TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer.

Byrd TT, Fousek K, Pignata A, Szot C, Samaha H, Seaman S, Dobrolecki L, Salsman VS, Oo HZ, Bielamowicz K, Landi D, Rainusso N, Hicks J, Powell S, Baker ML, Wels WS, Koch J, Sorensen PH, Deneen B, Ellis MJ, Lewis MT, Hegde M, Fletcher BS, St Croix B, Ahmed N. Byrd TT, et al. Among authors: fletcher bs. Cancer Res. 2018 Jan 15;78(2):489-500. doi: 10.1158/0008-5472.CAN-16-1911. Epub 2017 Nov 28. Cancer Res. 2018. PMID: 29183891 Free PMC article.

6

Bcl-2 mediated modulation of vascularization in prostate cancer xenografts.

Sakai Y, Goodison S, Kusmartsev S, Fletcher B, Eruslanov E, Cao W, Porvasnik S, Namiki K, Anai S, Rosser CJ. Sakai Y, et al. Among authors: fletcher b. Prostate. 2009 Apr 1;69(5):459-70. doi: 10.1002/pros.20888. Prostate. 2009. PMID: 19107861

7

Targeting tumor endothelial marker 8 in the tumor vasculature of colorectal carcinomas in mice.

Fernando S, Fletcher BS. Fernando S, et al. Cancer Res. 2009 Jun 15;69(12):5126-32. doi: 10.1158/0008-5472.CAN-09-0725. Cancer Res. 2009. PMID: 19528090

8

Sleeping beauty transposon-mediated nonviral gene therapy.

Fernando S, Fletcher BS. Fernando S, et al. BioDrugs. 2006;20(4):219-29. doi: 10.2165/00063030-200620040-00003. BioDrugs. 2006. PMID: 16831021 Review.

9

Functional cloning of SPIN-2, a nuclear anti-apoptotic protein with roles in cell cycle progression.

Fletcher BS, Dragstedt C, Notterpek L, Nolan GP. Fletcher BS, et al. Leukemia. 2002 Aug;16(8):1507-18. doi: 10.1038/sj.leu.2402557. Leukemia. 2002. PMID: 12145692

10

The WD-repeat protein GRWD1: potential roles in myeloid differentiation and ribosome biogenesis.

Gratenstein K, Heggestad AD, Fortun J, Notterpek L, Pestov DG, Fletcher BS. Gratenstein K, et al. Genomics. 2005 Jun;85(6):762-73. doi: 10.1016/j.ygeno.2005.02.010. Genomics. 2005. PMID: 15885502

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

447 results

Search Page